[Tardyferon-depot in the treatment of iron deficiency anemia].
Tardyferon was administered to 51 patients with iron deficiency anaemia. The drug was very well tolerated and even after administration to fasting patients it was tolerated well by 92% of patients. The iron absorption curve was on the average twice as high after 1 hour and increased up to 3 hours. A significant therapeutic effect with raised haemoglobin level by 10--27% was obtained after 4--6 weeks of treatment in 44 patients (86%). In the remaining cases the improvement was less pronounced.
D000293:Adolescent; D000328:Adult; D000747:Anemia, Hypochromic / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D005296:Ferrous Compounds / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009077:Mucins / Q000627:therapeutic use*; D011247:Pregnancy
D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005296:Ferrous Compounds; D009077:Mucins; C009380:ferrous sulfate, mucin drug combination; D007501:Iron
Tardyferon-depot w leczeniu niedokrwistości z neidoboru zelaza